IP Library Granted Patent US 9,827,083
Granted Patent B2
US 9,827,083 · App. 13/568,093 · Granted Nov 28, 2017

Pelvic implant system and method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,827,083
App. No.
13/568,093
Granted
Nov 28, 2017
Kind
B2
Abstract

Systems and methods are provided and adapted to engage and pull (e.g., pull up) or reposition urethral support tissue, such as the portion of the perineal membrane above or below the urethra. The perineal membrane intersects the urethra and vagina at the midurethra or distal location and can thus be stabilized or controlled in a manner that helps restore continence.

Claims (19)

1. A urethral support system for treating incontinence in a patient, comprising:

an elongate first implant device having a first end and a second end, the first implant device having a first medial device having a medial width and provided at the first end of the first implant device and adapted to anchor into a portion of the perineal membrane above the urethra of the patient and not below the urethra, the first medial device having a first anchor portion, a second anchor portion, and an aperture disposed between the first anchor portion and the second anchor portion, the first implant device having a first suture configured to extend through the aperture, and a first distal anchor device provided at the second end of the first implant device and operatively connected to the first medial device via the first suture, at least the medial width of the first medial device being larger than a width of the first suture, the first distal anchor device adapted to engage tissue distal to the perineal membrane;

an elongate second implant device, physically separate from and unconnected to the first implant device, having a first end and a second end, the second implant device having a second medial device provided at the first end of the second implant device and adapted to anchor into a portion of the perineal membrane above, and not below, the urethra of the patient spaced away from the first implant device, the second medial device having a first anchor portion, a second anchor portion, and an aperture disposed between the first anchor portion of the second medial device and the second anchor portion of the second medial device, the second implant device having a second suture configured to extend through the aperture of the second medial device, and a second distal anchor device provided at the second end of the second implant device and operatively connected to the second medial device via the second suture, the second distal anchor device adapted to engage tissue distal to the perineal membrane.

2. The system of claim 1 , wherein the first distal anchor device includes a first array of anchors, each of the first array of anchors having expandable barbs.

3. The system of claim 1 , wherein the first anchor portion of the first medial device includes one or more first barbs, and the second anchor portion of the first medial device includes one or more second barbs.

4. The system of claim 1 , wherein the first distal anchor device of the first implant device is adapted to engage a target tissue site selected from the group consisting of: the obturator foramen, obturator intemus, abdominal fascia, sacrospinous ligament, prepubic fascia, rectus fascia, the tendinous arch of the levator ani, the Cooper's ligament, and the pubic symphysis cartilage.

5. The system of claim 1 , wherein the first medial device of the first implant device is a mesh device.

6. The system of claim 1 , wherein the first medial device of the first implant device is a plate device.

7. The system of claim 1 , wherein the first medial device of the first implant device is a toggle tissue anchor device.

8. The system of claim 1 , wherein the first medial device of the first implant device is at least partially flexible.

9. The system of claim 1 , wherein the first medial device of the first implant device is at least partially rigid.

10. A urethral support system for treating incontinence in a patient, comprising:

an elongate first implant device having a first end and a second end, the first implant device having a first medial device provided at the first end of the first implant device and adapted to anchor into a portion of and span across a portion of the perineal membrane adjacent the urethra of the patient, the first medial device having a first anchor portion, a second anchor portion, and an aperture disposed between the first anchor portion and the second anchor portion, the first implant device having a first suture configured to extend through the aperture, the first suture having a first end portion and a second end portion, the first implant device including a first distal anchor device provided at the second end of the first implant device, the first distal anchor device being coupled to the first end portion of the first suture, the first distal anchor device adapted to engage tissue superior to the perineal membrane;

an elongate second implant device, not connected to and physically separate and spaced from the first implant device, having a first end and a second end, the second implant device having a second medial device provided at the first end of the second implant device and adapted to anchor into a portion of and span across a portion of the perineal membrane adjacent the urethra of the patient spaced away from the first implant device, the second medial device having a first anchor portion, a second anchor portion, and an aperture disposed between the first anchor portion of the second medial device and the second anchor portion of the second medial device, the second implant device having a second suture configured to extend through the aperture of the second medial device, the second suture having a first end portion and a second end portion, the second implant device including a distal anchor device provided at the second end of the second implant device, the second distal anchor device being coupled to the first end portion of the second suture, the second distal anchor device adapted to engage tissue superior to the perineal membrane.

11. The system of claim 10 , wherein the second distal anchor device includes a first array of anchors, each of the first array of anchors having expandable barbs.

12. The system of claim 10 , further including:

a first suture lock coupled to the second end portion of the first suture; and

a second suture lock coupled to the second end portion of the second suture.

13. The system of claim 10 , wherein the first distal anchor device of the first implant device is adapted to engage a target tissue site selected from the group consisting of: the obturator foramen, obturator intemus, abdominal fascia, sacrospinous ligament, prepubic fascia, rectus fascia, the tendinous arch of the levator ani, the Cooper's ligament, and the pubic symphysis cartilage.

Assignments (12)
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: ASTORA WOMEN'S HEALTH, LLC; ENDO HEALTH SOLUTIONS INC.; ASTORA WOMEN'S HEALTH HOLDINGS, LLC
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043777/0895 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: BOSTON SCIENTIFIC CORPORATION
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 043778/0167 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA; PREVIOUSLY RECORDED ON REEL 037300 FRAME 0199. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Feb 25, 2016
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 037916/0028 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037473/0745 →
CHANGE OF NAME Recorded Jan 11, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037473/0919 →
CORRECTIVE ASSIGNMENT THE INVENTOR NAME, ARNAL DELETED PREVIOUSLY RECORDED AT REEL: 029403 FRAME: 0059. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Dec 22, 2015
From: ALLEN, JOHN J.; MUJWID, JAMES R.; FELTON, JESSICA E.; SJOGARD, DAVID J.
To: AMS RESEARCH CORPORATION
Reel/Frame 037359/0203 →
CHANGE OF NAME Recorded Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0199 →
RELEASE OF SECURITY INTEREST Recorded Aug 6, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AMERICAN MEDICAL SYSTEMS, LLC; AMS RESEARCH, LLC; LASERSCOPE
Reel/Frame 036285/0146 →
GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.; LASERSCOPE
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 28, 2012
From: ALLEN, JOHN J.; MUJWID, JAMES R.; ARNAL, KEVIN R.; FELTON, JESSICA E.; SOGARD, DAVID J.
To: AMS RESEARCH CORPORATION
Reel/Frame 029362/0288 →